GL Rapha

GL Rapha is a South Korean pharmaceutical company and Contract Development and Manufacturing Organization (CDMO) founded in 2007. The company specializes in the development, manufacturing, and global distribution of biopharmaceuticals, with a significant presence in the Middle East and North Africa (MENA) regions. GL Rapha gained international prominence as a key manufacturing partner for the Russian Direct Investment Fund (RDIF), producing the Sputnik V and Sputnik Light COVID-19 vaccines. Through its subsidiary, Hankook Korus Pharm, the company operates advanced facilities for biologics production, including recombinant proteins and vaccines. Its broader portfolio includes a variety of generic medications and healthcare products aimed at improving global access to medicine.